As known, the immune system is closely associated with the progression of inflammation of the cardiovascular system.
A remarkable point is that rifampicin, a commonly used anti-tuberculosis drug, decreases bioavailability of corticosteroids; hence, this may contribute to the progression of inflammation.
Furthermore, inhibition of Notch1 with siRNA-NPs resulted in retarded progression of inflammation, bone erosion, and cartilage damage in CIA mice.
In vitro studies have suggested that resistin participates in the progression of inflammation and its pro-inflammatory effects may be mediated by activating the c-Jun-N-terminal kinase (JNK) and NF-κB pathways (Zhang et al., 2010).
Environmental changes, genetic factors, intestinal microbiota alterations and immune system deregulation contribute to the initiation and progression of inflammation and consequently fibrosis, the two main components of IBD [3].
While important genes and signaling pathways have been identified downstream of Ron signaling during progression of inflammation by this approach, the precise role that Ron receptor plays in regulating the transcriptional landscape in macrophages, and particular in isolated Kupffer cells, has still not been investigated.
HA is involved in the initiation and progression of inflammation at both cellular and extracellular levels [5], [6].
IL-10 has profound autoregulatory and primarily negative effects on macrophage activation [33] and macrophages are believed to play a key role during the progression of inflammation.
By the anti-inflammatory effects of the ligation of adenosine to the A2AR, the described receptor subtype switch alters the progression of inflammation toward resolution.
Therefore, timing of intervention and dosage regimes appears to be key determinants for the protective or symptomatic effect of exogenous corticosteroids on the progression of inflammation.
For histopathological analysis of the progression of inflammation and tissue damage in the time course experiment animals were sacrificed at 10, 13, 20 and 50 days post EAE induction (n = 4 5 per group at each time point).
